Dr. Nathalie Zeitouni, MD
Claim this profileMedical Dermatology Specialists
Studies Cancer
Studies Basal Cell Carcinoma
7 reported clinical trials
11 drugs studied
Area of expertise
1Cancer
PTCH1 positive
Stage III
Stage IV
2Basal Cell Carcinoma
PTCH1 positive
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Nathalie Zeitouni, MD is currently running
RP1
for Advanced Skin Cancer in Transplant Patients
This trial tests RP1, a modified virus, in organ transplant recipients with advanced skin cancer. RP1 works by killing cancer cells and boosting the immune system to fight the cancer. The HIV-1 accessory protein Vpr has been shown to induce cell cycle arrest and kill tumor cells by apoptosis.
Recruiting1 award Phase 1 & 210 criteria
BF-200 ALA + PDT
for Actinic Keratosis
The aim of this study is to test the safety. tolerability and efficacy of field-directed photodynamic therapy (PDT) with 10% aminolevulinic acid gel (Ameluz®, BF-200 ALA) in combination with one of the narrow spectrum red light RhodoLED lamps in comparison to vehicle treatment for actinic keratosis (AK) on the extremities and neck/trunk.
Recruiting1 award Phase 39 criteria
More about Nathalie Zeitouni, MD
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Nathalie Zeitouni, MD has experience with
- BF-200 ALA (Ameluz®)
- Dietary Vitamin D3 Pre-treatment
- Serum Maintenance Vitamin D3
- Photodynamic Therapy
- Levulan® Kerastick® For Topical Solution
- BLU-U® Blue Light Photodynamic Therapy Illuminator
Breakdown of trials Nathalie Zeitouni, MD has run
Cancer
Basal Cell Carcinoma
Keratoderma Blennorrhagicum
Skin Cancer
Actinic Keratosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nathalie Zeitouni, MD specialize in?
Nathalie Zeitouni, MD focuses on Cancer and Basal Cell Carcinoma. In particular, much of their work with Cancer has involved PTCH1 positive patients, or patients who are Stage III.
Is Nathalie Zeitouni, MD currently recruiting for clinical trials?
Yes, Nathalie Zeitouni, MD is currently recruiting for 2 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Nathalie Zeitouni, MD has studied deeply?
Yes, Nathalie Zeitouni, MD has studied treatments such as BF-200 ALA (Ameluz®), Dietary Vitamin D3 pre-treatment, Serum Maintenance Vitamin D3.
What is the best way to schedule an appointment with Nathalie Zeitouni, MD?
Apply for one of the trials that Nathalie Zeitouni, MD is conducting.
What is the office address of Nathalie Zeitouni, MD?
The office of Nathalie Zeitouni, MD is located at: Medical Dermatology Specialists, Phoenix, Arizona 85006 United States. This is the address for their practice at the Medical Dermatology Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.